0

Neurological Biomarkers Market by Indication, End-user, and Geography - Forecast and Analysis 2022-2026

  • Published: Jun 2022
  • Pages: 158
  • SKU: IRTNTR73380
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The neurological biomarkers market share is expected to increase to USD 6.00 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 12.43%.

This neurological biomarkers market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers neurological biomarkers market segmentations by indication (AD, PD, ASD, MS, and Others), end-user (hospitals, clinical diagnostic centers, and research organizations and others), and geography (North America, Europe, Asia, and Rest of World (ROW)). The neurological biomarkers market report also offers information on several market vendors, including Bio Rad Laboratories Inc., Proteome Sciences plc, QIAGEN NV, Thermo Fisher Scientific Inc., Merck KGaA, F. Hoffmann La Roche Ltd., Myriad Genetics Inc., bioMerieux SA, Charles River Laboratories International Inc., Quest Diagnostics Inc., PerkinElmer Inc., Metabolon Inc., Acrobiosystems Inc., HU Group Holdings Inc., Enzo Biochem Inc., Eli Lilly and Co., Abbott Laboratories, Advanced Brain Monitoring Inc., Johnson and Johnson, and Quanterix Corp. among others.

What will the Neurological Biomarkers Market Size be During the Forecast Period?

Neurological Biomarkers Market Size

Download the Free Report Sample to Unlock the Neurological Biomarkers Market Size for the Forecast Period and Other Important Statistics

 

Neurological Biomarkers Market: Key Drivers, Trends, and Challenges

The increasing incidences of neurological disorders is notably driving the neurological biomarkers market growth, although factors such as unmet market needs for effective validation of biomarkers may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the neurological biomarkers industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Neurological Biomarkers Market Driver

  • The increasing incidences of neurological disorders is one of the key drivers supporting the neurological biomarkers market growth.
  • Patients with a comprehensive range of neurological disorders, including epilepsy, stroke, Parkinsons disease, and brain tumors, have a high risk of developing a disability.
  • According to the Centers for Disease Control and Prevention (CDC), the prevalence of Parkinsons disease increases from 1% to 4% in the aging population of 60 years to 80 years. The prevalence of the disease is more common among the geriatric population.
  • As per The Lancet Global Health Report 2021, the burden of non-communicable neurological disorders is increasing in India mainly due to the aging of the population. Stroke, headache disorders, and epilepsy are the leading contributors to neurological disorders burden in India.
  • The treatment of brain hemorrhage, which occurs due to stroke and brain tumors, is boosting the demand for neurological biomarkers. For instance, in September 2021, the CDC reported that 798,000 people are affected by strokes in the US every year. Thus, the increasing incidences of stroke will drive the neurological biomarkers market growth during the forecast period.

Key Neurological Biomarkers Market Trend

  • Increasing focus on accurate neurological diagnostics is one of the key neurological biomarkers market trends contributing to the market growth.
  • Brain injuries such as TBIs leave serious and lasting damage to people. CT scans have been commonly used to check bleeding or swelling in the brain but fail to detect accurate results in most cases.
  • The inability of CT scans leaves a gap in which many brain injuries go unrecognized and undiagnosed. Therefore, blood tests for detecting neurological biomarkers have gained traction in recent years.
  • Vendors are developing clinical trials and R&D of biomarkers, which will give more accurate results for neurological disorders and will drive the demand for neurological biomarkers during the forecast period.
  • In August 2020, Enigma Biomedical Group (EBG) announced the execution of the development, licensing, and option agreement of two project agreements to evaluate novel neuroimaging biomarkers from Janssen Pharmaceutica NV subsidiary of Johnson and Johnson Services, Inc. Such developments will contribute to the neurological biomarkers market growth during the forecast period.

Key Neurological Biomarkers Market Challenge

  • Unmet market needs for effective validation of biomarkers is one of the factors hampering the neurological biomarkers market growth.
  • Genuine limitations, such as reproduction of positive clinical trial results, the absence of early pre-analytical examinations, the absence of autonomous check of results, and failure of investigators to assess whether the use of the biomarker would improve clinical practice to the benefit of neuro patients are hindering diagnostic neurological biomarker validation.
  • Innovative evaluation of fluid-based proteomics enables biomarkers identification as indicators of the onset of neurological disease has been complex and incurs high research costs.
  • The challenges for the discovery of biomarkers for neurological diseases can be addressed with functional disease assessment of the samples taken from the brain, CSF, and plasma.
  • The new advances represent the test of how particular markers or combinations of markers can be accepted for their planned use in clinical examination, drug development, or clinical practice. However, the challenges are difficult to overcome and will negatively impact the neurological biomarkers market in focus during the forecast period.

This neurological biomarkers market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global neurological biomarkers market as a part of the global biotechnology market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the neurological biomarkers market during the forecast period.

Who are the Major Neurological Biomarkers Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

  • Bio Rad Laboratories Inc.
  • Proteome Sciences plc
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • F. Hoffmann La Roche Ltd.
  • Myriad Genetics Inc.
  • bioMerieux SA
  • Charles River Laboratories International Inc.
  • Quest Diagnostics Inc.
  • PerkinElmer Inc.
  • Metabolon Inc.
  • Acrobiosystems Inc.
  • HU Group Holdings Inc.
  • Enzo Biochem Inc.
  • Eli Lilly and Co.
  • Abbott Laboratories
  • Advanced Brain Monitoring Inc.
  • Johnson and Johnson
  • Quanterix Corp.

 

This statistical study of the neurological biomarkers market encompasses successful business strategies deployed by the key vendors. The neurological biomarkers market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

  • Bio Rad Laboratories Inc. - The life science segment develops, manufactures, sells, and services reagents, apparatus, and instruments that are used for biological research. 
  • Bio Rad Laboratories Inc. - The company offers neurological biomarkers including proteomic and genomic biomarker. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The neurological biomarkers market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Neurological Biomarkers Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the neurological biomarkers market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Neurological Biomarkers Market?

Neurological Biomarkers Market Market segmentation by region

For more insights on the market share of various regions Request for a FREE sample now!

43% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for neurological biomarkers market in North America. Market growth in this region will be slower than the growth of the market in Asia.

The increasing demand for the diagnosis of neurological disorders will facilitate the neurological biomarkers market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The outbreak of COVID had a positive impact on the regional market. Moreover, the initiation of large-scale COVID-19 vaccination drives by the government in Q4 2020 returned the regional economy on track and led to a significant reduction in the number of COVID-19 patients. This, in turn, led to the lifting of cross-border restrictions and the resumption of healthcare facilities, which is expected to drive the growth of the regional neurological biomarkers market in focus during the forecast period.

What are the Revenue-generating Indication Segments in the Neurological Biomarkers Market?

Neurological Biomarkers Market Segmentation

To gain further insights on the market contribution of various segments Request for a FREE sample

The neurological biomarkers market share growth by the AD segment will be significant during the forecast period. AD is a brain disorder that destroys memory and thinking skills and, eventually, the ability to carry out simple tasks. The diagnostic guidelines of AD have been re-designed to incorporate the use of brain imaging and CSF biomarkers to check whether an individual has progressing AD neuropathological process. Neurobiological biomarkers are an effective tool for the early detection of AD, and they indicate progressive development before the main manifestations of the disease. Thus, such factors of the AD will boost the neurological biomarkers market growth during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the neurological biomarkers market size and actionable market insights on post COVID-19 impact on each segment.

 

Neurological Biomarkers Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 12.43%

Market growth 2022-2026

$ 6.00 billion

Market structure

Fragmented

YoY growth (%)

11.75

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 43%

Key consumer countries

US, Canada, Germany, UK, and France

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Bio Rad Laboratories Inc., Proteome Sciences plc, QIAGEN NV, Thermo Fisher Scientific Inc., Merck KGaA, F. Hoffmann La Roche Ltd., Myriad Genetics Inc., bioMerieux SA, Charles River Laboratories International Inc., Quest Diagnostics Inc., PerkinElmer Inc., Metabolon Inc., Acrobiosystems Inc., HU Group Holdings Inc., Enzo Biochem Inc., Eli Lilly and Co., Abbott Laboratories, Advanced Brain Monitoring Inc., Johnson and Johnson, and Quanterix Corp.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Neurological Biomarkers Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive neurological biomarkers market growth during the next five years
  • Precise estimation of the neurological biomarkers market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the neurological biomarkers industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of neurological biomarkers market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Indication
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 14: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 18: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 19: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 20: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 21: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 22: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 23: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 24: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Indication

    • 5.1 Market segments
      • Exhibit 25: Chart on Indication - Market share 2021-2026 (%)
      • Exhibit 26: Data Table on Indication - Market share 2021-2026 (%)
    • 5.2 Comparison by Indication
      • Exhibit 27: Chart on Comparison by Indication
      • Exhibit 28: Data Table on Comparison by Indication
    • 5.3 AD - Market size and forecast 2021-2026
      • Exhibit 29: Chart on AD - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Data Table on AD - Market size and forecast 2021-2026 ($ million)
      • Exhibit 31: Chart on AD - Year-over-year growth 2021-2026 (%)
      • Exhibit 32: Data Table on AD - Year-over-year growth 2021-2026 (%)
    • 5.4 PD - Market size and forecast 2021-2026
      • Exhibit 33: Chart on PD - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Data Table on PD - Market size and forecast 2021-2026 ($ million)
      • Exhibit 35: Chart on PD - Year-over-year growth 2021-2026 (%)
      • Exhibit 36: Data Table on PD - Year-over-year growth 2021-2026 (%)
    • 5.5 ASD - Market size and forecast 2021-2026
      • Exhibit 37: Chart on ASD - Market size and forecast 2021-2026 ($ million)
      • Exhibit 38: Data Table on ASD - Market size and forecast 2021-2026 ($ million)
      • Exhibit 39: Chart on ASD - Year-over-year growth 2021-2026 (%)
      • Exhibit 40: Data Table on ASD - Year-over-year growth 2021-2026 (%)
    • 5.6 MS - Market size and forecast 2021-2026
      • Exhibit 41: Chart on MS - Market size and forecast 2021-2026 ($ million)
      • Exhibit 42: Data Table on MS - Market size and forecast 2021-2026 ($ million)
      • Exhibit 43: Chart on MS - Year-over-year growth 2021-2026 (%)
      • Exhibit 44: Data Table on MS - Year-over-year growth 2021-2026 (%)
    • 5.7 Others - Market size and forecast 2021-2026
      • Exhibit 45: Chart on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 46: Data Table on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Chart on Others - Year-over-year growth 2021-2026 (%)
      • Exhibit 48: Data Table on Others - Year-over-year growth 2021-2026 (%)
    • 5.8 Market opportunity by Indication
      • Exhibit 49: Market opportunity by Indication ($ million)

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Exhibit 50: Chart on End-user - Market share 2021-2026 (%)
      • Exhibit 51: Data Table on End-user - Market share 2021-2026 (%)
    • 6.2 Comparison by End-user
      • Exhibit 52: Chart on Comparison by End-user
      • Exhibit 53: Data Table on Comparison by End-user
    • 6.3 Hospitals - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)
    • 6.4 Clinical diagnostic centers - Market size and forecast 2021-2026
      • Exhibit 58: Chart on Clinical diagnostic centers - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on Clinical diagnostic centers - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on Clinical diagnostic centers - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on Clinical diagnostic centers - Year-over-year growth 2021-2026 (%)
    • 6.5 Research organizations and others - Market size and forecast 2021-2026
      • Exhibit 62: Chart on Research organizations and others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on Research organizations and others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on Research organizations and others - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on Research organizations and others - Year-over-year growth 2021-2026 (%)
    • 6.6 Market opportunity by End-user
      • Exhibit 66: Market opportunity by End-user ($ million)

    7 Customer Landscape

    • 7.1 Customer landscape overview
      • Exhibit 67: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    8 Geographic Landscape

    • 8.1 Geographic segmentation
      • Exhibit 68: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 69: Data Table on Market share by geography 2021-2026 (%)
    • 8.2 Geographic comparison
      • Exhibit 70: Chart on Geographic comparison
      • Exhibit 71: Data Table on Geographic comparison
    • 8.3 North America - Market size and forecast 2021-2026
      • Exhibit 72: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 73: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 74: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 75: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 8.4 Europe - Market size and forecast 2021-2026
      • Exhibit 76: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 77: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 78: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 79: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 8.5 Asia - Market size and forecast 2021-2026
      • Exhibit 80: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 81: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 82: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 83: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 8.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 84: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 85: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 86: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 87: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 8.7 US - Market size and forecast 2021-2026
      • Exhibit 88: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 89: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 90: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 91: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 8.8 Germany - Market size and forecast 2021-2026
      • Exhibit 92: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 93: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 94: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 95: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 8.9 UK - Market size and forecast 2021-2026
      • Exhibit 96: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 97: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 98: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 99: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 8.10 Canada - Market size and forecast 2021-2026
      • Exhibit 100: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 101: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 102: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 103: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 8.11 France - Market size and forecast 2021-2026
      • Exhibit 104: Chart on France - Market size and forecast 2021-2026 ($ million)
      • Exhibit 105: Data Table on France - Market size and forecast 2021-2026 ($ million)
      • Exhibit 106: Chart on France - Year-over-year growth 2021-2026 (%)
      • Exhibit 107: Data Table on France - Year-over-year growth 2021-2026 (%)
    • 8.12 Market opportunity by geography
      • Exhibit 108: Market opportunity by geography ($ million)

    9 Drivers, Challenges, and Trends

    • 9.1 Market drivers
      • 9.2 Market challenges
        • 9.3 Impact of drivers and challenges
          • Exhibit 109: Impact of drivers and challenges in 2021 and 2026
        • 9.4 Market trends

          10 Vendor Landscape

          • 10.1 Overview
            • 10.2 Vendor landscape
              • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
            • 10.3 Landscape disruption
              • Exhibit 111: Overview on factors of disruption
            • 10.4 Industry risks
              • Exhibit 112: Impact of key risks on business

            11 Vendor Analysis

            • 11.1 Vendors covered
              • Exhibit 113: Vendors covered
            • 11.2 Market positioning of vendors
              • Exhibit 114: Matrix on vendor position and classification
            • 11.3 Bio Rad Laboratories Inc.
              • Exhibit 115: Bio Rad Laboratories Inc. - Overview
              • Exhibit 116: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 117: Bio Rad Laboratories Inc. - Key news
              • Exhibit 118: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 119: Bio Rad Laboratories Inc. - Segment focus
            • 11.4 bioMerieux SA
              • Exhibit 120: bioMerieux SA - Overview
              • Exhibit 121: bioMerieux SA - Business segments
              • Exhibit 122: bioMerieux SA - Key offerings
              • Exhibit 123: bioMerieux SA - Segment focus
            • 11.5 Charles River Laboratories International Inc.
              • Exhibit 124: Charles River Laboratories International Inc. - Overview
              • Exhibit 125: Charles River Laboratories International Inc. - Business segments
              • Exhibit 126: Charles River Laboratories International Inc. - Key news
              • Exhibit 127: Charles River Laboratories International Inc. - Key offerings
              • Exhibit 128: Charles River Laboratories International Inc. - Segment focus
            • 11.6 F. Hoffmann La Roche Ltd.
              • Exhibit 129: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 130: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 131: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 132: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 133: F. Hoffmann La Roche Ltd. - Segment focus
            • 11.7 Merck KGaA
              • Exhibit 134: Merck KGaA - Overview
              • Exhibit 135: Merck KGaA - Business segments
              • Exhibit 136: Merck KGaA - Key news
              • Exhibit 137: Merck KGaA - Key offerings
              • Exhibit 138: Merck KGaA - Segment focus
            • 11.8 Myriad Genetics Inc.
              • Exhibit 139: Myriad Genetics Inc. - Overview
              • Exhibit 140: Myriad Genetics Inc. - Product / Service
              • Exhibit 141: Myriad Genetics Inc. - Key offerings
            • 11.9 Proteome Sciences plc
              • Exhibit 142: Proteome Sciences plc - Overview
              • Exhibit 143: Proteome Sciences plc - Product / Service
              • Exhibit 144: Proteome Sciences plc - Key offerings
            • 11.10 QIAGEN NV
              • Exhibit 145: QIAGEN NV - Overview
              • Exhibit 146: QIAGEN NV - Product / Service
              • Exhibit 147: QIAGEN NV - Key news
              • Exhibit 148: QIAGEN NV - Key offerings
            • 11.11 Quanterix Corp.
              • Exhibit 149: Quanterix Corp. - Overview
              • Exhibit 150: Quanterix Corp. - Product / Service
              • Exhibit 151: Quanterix Corp. - Key offerings
            • 11.12 Thermo Fisher Scientific Inc.
              • Exhibit 152: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 153: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 154: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 155: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 156: Thermo Fisher Scientific Inc. - Segment focus

            12 Appendix

            • 12.1 Scope of the report
              • 12.2 Inclusions and exclusions checklist
                • Exhibit 157: Inclusions checklist
                • Exhibit 158: Exclusions checklist
              • 12.3 Currency conversion rates for US$
                • Exhibit 159: Currency conversion rates for US$
              • 12.4 Research methodology
                • Exhibit 160: Research methodology
                • Exhibit 161: Validation techniques employed for market sizing
                • Exhibit 162: Information sources
              • 12.5 List of abbreviations
                • Exhibit 163: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your sample now!
              Neurological Biomarkers Market market growth will increase by $6.00 bn during 2022-2026.
              The neurological biomarkers market market is expected to grow at a CAGR of 12.43% during 2022-2026.
              Technavio has segmented the neurological biomarkers market market by other 1 (AD, PD, ASD, MS, and Others) ,end-user (Hospitals, Clinical diagnostic centers, and Research organizations and others) , and geography (North America, Europe, Asia, and Rest of World (ROW)).
              Bio Rad Laboratories Inc., Proteome Sciences plc, QIAGEN NV, Thermo Fisher Scientific Inc., Merck KGaA, F. Hoffmann La Roche Ltd., Myriad Genetics Inc., bioMerieux SA, Charles River Laboratories International Inc., Quest Diagnostics Inc., PerkinElmer Inc., Metabolon Inc., Acrobiosystems Inc., HU Group Holdings Inc., Enzo Biochem Inc., Eli Lilly and Co., Abbott Laboratories, Advanced Brain Monitoring Inc., Johnson and Johnson, Quanterix Corp. are a few of the key vendors in the neurological biomarkers market market.
              North America will register the highest growth rate of 43% among the other regions. Therefore, the neurological biomarkers market market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the neurological biomarkers market market growth are:
              • Increasing incidences of neurological disorders
              • Increasing focus on accurate neurological diagnostics
              The neurological biomarkers market market vendors should focus on grabbing business opportunities from the ad segment as it accounted for the largest market share in the base year.
              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?
              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis

              Certified ISO 9001 : 2015

              We are ISO recognized

              We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

              We are GDPR and CCPA compliant

              We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

              Safe and Secure SSL Encrypted
              Technavio

              info
              close
              • Single:

                One user only.
                Quick & easy download option

              • Enterprise:

                Unlimited user access (Within your organization)
                Complimentary Customization Included

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Customized Report as per your Business Needs

              • Our analysts will work directly with you and understand your needs
              • Get data on specified regions or segments, competitor and Vendors
              • Data will be formatted and presented as per your requirements
              • We offer $1000 worth of FREE customization at the time of purchase

              Let us help you make report more suited to your requirements.

              • Get a competitive breakdown as per your niche industry
              • Customize the data with various metrics that meet your business prerequisite
              • Understand Revenue Sources, Customers and many more
              • Details on Market Share
              • These customizations are done in a short amount of time by our analysts and industry experts
              Technavio
              Enquire Before Buying
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>